专利检索 ap:("BOEHRINGER INGELHEIM VETMEDICA GMBH" OR "University of Georgia Research Foundation, Inc.") AND inv:"Bianca Natália FERREIRA DE MOURA LOURENCO" 第 1 页

1.

发明申请
TELMISARTAN FOR THE TREATMENT OF HYPERTENSION IN DOGS 有权

公开(公告)号：US20220226290A1

公开(公告)日：2022-07-21

申请号：US17596356

申请日：2020-04-30

申请人： BOEHRINGER INGELHEIM VETMEDICA GMBH , University of Georgia Research Foundation, Inc.

发明人： Anne Michelle TRAAS , Amanda ERICKSON COLEMAN , Bianca Natália FERREIRA DE MOURA LOURENCO , Kate Elizabeth CREEVY , Scott Alan Brown

IPC分类号： A61K31/4184 , A61P9/12 , A61K45/06

摘要： The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of hypertension in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that is varied over a treatment period.

2.

发明申请
TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS 有权

公开(公告)号：US20220218671A1

公开(公告)日：2022-07-14

申请号：US17596351

申请日：2020-04-30

申请人： BOEHRINGER INGELHEIM VETMEDICA GMBH , University of Georgia Research Foundation, Inc.

发明人： Anne Michelle TRAAS , Amanda ERICKSON COLEMAN , Bianca Natália FERREIRA DE MOURA LOURENCO , Kate Elizabeth CREEVY , Scott Alan Brown

IPC分类号： A61K31/4184 , A61K45/06 , A61P13/12 , A61P9/12

摘要： The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that is varied over a treatment period.